Big Pharma Success – Oral Covid Drugs

Wow! I had no idea my blog was influencing the FDA! Within hours of my last blog, the FDA authorized both new oral antiviral drugs, Pfizer’s Paxlovid and Merck’s Molnupiravir. That’s just what I called for in my last post, Covid Therapeutics Taking a Back Seat. Seriously, I’m sure my blog had nothing to do with it; but it’s nice to see the government finally coming around to thinking like many physicians like myself. It’s great to push vaccines, which are very important, but therapeutic innovations like these two new oral treatments for Covid can be equally impressive in helping us return to some sense of normalcy.

But the news is not all good. Since the FDA was so slow to approve these drugs, and the Biden Administration was slow to appreciate their importance, these  pharmaceutical advances in therapeutics will be in short supply this winter. The Emergency Use Authorization (EUA) of the FDA is actually only for adults at high risk of severe illness. Both drugs will be available by prescription only with proof of a positive Covid test and should be taken within five days of symptom onset.

How do these drugs work? Both drugs interfere with virus replication, though by different means. Virus replication is the process of making more virus that leads to overwhelming the host. When drugs interfere with this process, they prevent the virus from spreading and the host immune system overwhelms the virus. Molnupiravir was found to reduce hospitalizations by about 30% and deaths by nearly 90%. Early results from its trial showed a 50% reduction in hospitalization, though efficacy declined later for unclear reasons. Paxlovid reduced hospitalization by about 90%.

Expect rationing of the drugs this winter. The Biden Administration ordered 10 million packs of Paxlovid in mid-November after strong preliminary trial results. But other countries have put in large orders, and Pfizer says it expects to manufacture 180,000 courses by the end of this year. Pfizer has licensed the drug to the Medicines Patent Pool to ramp up supply in lower-income countries, but production can take six to eight months. Advance government orders, like Operation Warp Speed for vaccines, might have accelerated production, says The Wall Street Journal.

The Biden Administration has ordered a mere 3.1 million treatment courses of Molnupiravir. The U.K. has purchased 2.2 million courses for its 68 million citizens. Most U.S. courses will be available by the end of January, but the FDA says the drug should only be used when other authorized treatments aren’t accessible or clinically appropriate. That means doctors are less likely to prescribe it.

The Wall Street Journal editorial board says, “Vaccines appear to have reduced the Biden Administration’s urgency to approve and accelerate new treatments, especially antivirals. Officials failed to foresee how vaccine efficacy would wane over time and demand would plateau. They can’t be faulted for that. But they could have hedged by fast-tracking oral treatments, as Operation Warp Speed did, by investing in multiple vaccine makers using different technology.”

The National Institutes of Health (NIH) also bears some of the blame. They bet heavily on monoclonal antibodies, which have been enormously helpful. But it overlooked the importance of other drugs for early treatment to prevent infected individuals from getting sicker. Early treatment therapeutics are the key to reducing hospitalizations. NIH was also late to fund a large trial on repurposing existing drugs such as the anti-parasitic ivermectin, anti-depressant fluvoxamine and asthma inhaling fluticasone. These drugs all show promising antiviral effects, but final results aren’t in yet.

We should celebrate the approval of these two new oral drugs to treat Covid, but it’s hard not to wonder how many more lives would have been saved if they had been approved earlier. WSJ says, “Vaccines have saved hundreds of thousands of lives, but many more would be saved if oral treatments like Paxlovid and Molnupiravir were available sooner. The drugs represent a huge pharmaceutical success but a missed government opportunity.”

Covid Therapeutics Taking a Back Seat

If you watched President Biden’s latest speech on the Covid pandemic this week, you heard lots of talk about getting vaccinated. He repeated this mantra multiple times, making it a matter of morality and patriotism, as well as personal health. Although I’m very pro-vaccine, I also believe in America we have the freedom to make our own decisions about our bodies. Pro-choice advocates are always choosing this argument for women who choose abortion, but not so much when it comes to freedom to choose to be vaccinated or not. Then it’s our patriotic duty!

What’s missing from the conversation is any talk about viral therapeutics. It’s great to have effective vaccines, but it’s a big step forward to have effective therapeutics, too. Not everyone can be vaccinated, either for medical, religious, or personal reasons. Effective therapeutics make it possible to treat those who get infected anyway – and many of those may also have been vaccinated.

Perhaps it goes back to President Trump, who was vilified by the media for suggesting hydroxychloroquine was an effective treatment of Covid. Despite all the negative media about this drug, it has proven effective in limiting the severity and duration of Covid-19. Today, however, we have even better therapeutics.

I’ve written earlier about oral treatment of Covid-19. (Covid Pill Should be Coming Soon) That blog was written nearly three months ago and we’re still waiting for FDA approval.

Dr. Marty Makary, Johns Hopkins Medical School professor, writes in The Wall Street Journal that the FDA has been delinquent in authorizing both Merck’s and Pfizer’s antiviral pills that are designed to work against all Covid variants. Merck’s molnupiravir received an up-vote from FDA experts three weeks ago, yet the agency hasn’t authorized it. Pfizer’s paxlovid cut Covid deaths to zero (compared with 10 deaths in the control group), yet the FDA has been sitting on the application for five weeks without even scheduling an advisory meeting to review it. What are they waiting for?

There are other effective therapeutics, too. Fluvoxamine reduced Covid deaths by 91% among symptomatic high-risk patients in a second randomized controlled trial evaluating its effect. Yet there is little mention of this drug by public-health officials. Ivermectin is another drug that has been in use since 1996 for treatment of river blindness and other diseases caused by parasites. Its safety and effectiveness have been proven over 25 years. Ivermectin has also been found to be effective against 21 viruses, including Covid-19. A single dose of ivermectin reduced the viral load of Covid-19 in cells by 99.8% in 24 hours and 99.98% in 48 hours, according to a June 2020 study published in the journal Antiviral Research. In August, 2021, I wrote of some 70 clinical trials currently evaluating the use of ivermectin for treating Covid-19 patients. (FDA Withholding Effective Covid Drug) Yet we’ve heard nothing from public-health officials since that time.

Furthermore, we hear little about natural immunity and its impact on our society. Yet those who have survived Covid-19 have developed their own natural immunity, which has been estimated in one study in Israel to be 27 times as effective as vaccines in preventing future infection.

Dr Makary says, “Last week I testified before Congress that many Covid policies are no longer driven by science. Data is being cherry-picked to support predetermined agendas, while the roles of natural immunity and life-saving therapeutics are being sidelined.”

Vaccines are great, a monumental achievement of the Trump Administration’s Operation Warp Speed. The world is a much safer place because of them and I recommend them to all who can safely be vaccinated. But there is also much room for celebrating – and using – viral therapeutics. What could be easier than taking a home test for Covid, then a pill to get you over the next few days of what should be a common cold-like illness? Then, we could all get back to life as it was before Covid.

Biden’s Vaccine Mandates Getting Crushed

The Wall Street Journal asks an intriguing question: “What legal sage advised President Biden to impose vaccine mandates?” They reason that legal adviser needs to have his law license pulled because the courts are repudiating the Biden Administration’s mandates at every opportunity.

A federal judge in Georgia is the latest to block the Administration’s vaccine requirement for employees of federal contractors – the fifth judicial rebuke in less than a month. Judge R. Stan Baker ruled in a challenge brought by seven states that the Administration had exceeded its authority under the Federal Property and Administrative Service Act.  The President claimed his executive order would “promote economy and efficiency in procurement” by contracting with sources “that provide adequate Covid-19 safeguards for their workforce.”

Judge Baker went on to say the law does not give the President “the right to impose virtually any kind of requirement on businesses that wish to contract with the Government (and, thereby, on those businesses’ employees) so long as he determines it could lead to a healthier and thus more efficient workforce or it could reduce absenteeism.”

Judge Baker is not alone. Last week federal Judge Gregory Van Tatenhove enjoined the Administration from enforcing the contractor mandate in Kentucky, Ohio, and Tennessee. While conceding that Congress delegated broad power to the president, the judge noted that his “authority is not absolute” and the President’s overreach raises “several concerning statutory and constitutional implications.” The mandate “intrudes on an area that is traditionally reserved to the States,” wrote this judge, noting the Constitution grants the states general police powers to regulate public health and welfare.

Two judges recently scored the Centers for Medicare and Medicaid Services (CMS) for exceeding its authority by mandating vaccines for employees of healthcare providers that receive government funds. The Social Security Act authorizes CMS to prescribe rules and regulations that may be necessary to carry out the Medicaid and Medicare programs. But these judges both noted the Supreme Court has said that Congress must “speak clearly if it wishes to assign to an agency, decisions of vast economic and political significance.”

Louisiana Judge Terry Doughty said, “If CMS has the authority by a general authorization statute to mandate vaccines, they have authority to do almost anything they believe necessary, holding the hammer of termination of the Medicare/Medicaid Provider Agreement.” This same judge blasted CMS for skipping notice-and-comment, and failing to consider surgical alternatives to its sweeping mandate and the reliance interest of states and providers on federal funds.

These recent judicial smackdowns come on the heels of the Fifth Circuit Court of Appeals’ ruling early last month that stayed the Occupational Safety and Health Administration’s vaccinate-or-test mandate for workers of employers with 100 or more employees. The Fifth Circuit ruled against the Biden Administration on procedural, statutory, and constitutional grounds.

The Biden Administration is still trying to convince federal employees these mandates are in their best interests. “The goal of the federal employee vaccination requirement is to protect federal workers, not to punish them,” wrote the Office of Personnel Management and Office of Management and Budget leaders to executive agencies.  They added, “We encourage your agencies to continue with robust education and counseling efforts through this holiday season as the first step in an enforcement process, with no subsequent enforcement actions.”

WSJ editors ask, “Why not do the same for private employers and workers? The White House is punishing private workers while inoculating government servants from its overreach.”

It’s time to stop the mandates. We’re nearly two years into this Covid-19 pandemic and every adult by now must know the risks of Covid-19 and the ways to mitigate that risk through vaccines, wearing masks, hand-sanitizing, and social distancing. Adults can make their own decisions about vaccines and those who choose to avoid vaccination have accepted the risks. If you’re worried about the virus, get vaccinated. If you’re more worried about the vaccines, then voluntarily take the necessary precautions. Let’s stop trying to control people. Vaccine mandates only disrupt our economy, impair the provision of necessary services, increase unemployment, and violate the civil liberties of all Americans.

The judicial branch consistently says they are illegal. Time to find better legal advisors, Mr. President.